13F-HR filed by MPM BIOIMPACT LLC
MPM BIOIMPACT LLC filed this 13F-HR for the quarter ended 2025-06-30, filed 2025-08-14, with 44 holding rows worth $577,150,843.
- Accession
- 0000950123-25-008431
- Filer
- CIK 1687078
- Filed
- 2025-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2025
A holdings report, 44 entries on the cover page, a total value of $577,150,843 stated on the cover page (in dollars after the unit check, H1), rows summing to $577,150,843 with VALUE read as dollars as filed, 13F file number 028-20107. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| CULLINAN THERAPEUTICS INC | 230031106 | COM | 7,648,268 | $57,591,458 | dollars as filed | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 100,415 | $30,389,596 | dollars as filed | |
| ZAI LAB LTD ADR | 98887Q104 | ADR | 745,060 | $26,054,748 | dollars as filed | |
| GUARDANT HEALTH INC COM | 40131M109 | Stock | 442,656 | $23,035,818 | dollars as filed | |
| ARS PHARMACEUTICALS INC | 82835W108 | COM | 1,303,399 | $22,744,313 | dollars as filed | |
| EDGEWISE THERAPEUTICS INC | 28036F105 | COM | 1,720,741 | $22,558,915 | dollars as filed | |
| AVIDITY BIOSCIENCES INC COM | 05370A108 | Stock | 760,022 | $21,584,625 | dollars as filed | |
| PTC THERAPEUTICS INC | 69366J200 | COM | 438,477 | $21,415,217 | dollars as filed | |
| TREVI THERAPEUTICS INC COM | 89532M101 | Stock | 3,406,955 | $18,636,044 | dollars as filed | |
| ORIC PHARMACEUTICALS INC | 68622P109 | COM | 1,729,378 | $17,553,187 | dollars as filed | |
| NATERA INC COM | 632307104 | Stock | 98,924 | $16,712,221 | dollars as filed | |
| ALKERMES PLC | G01767105 | SHS | 549,262 | $15,714,386 | dollars as filed | |
| MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD | 61559X104 | Stock | 313,571 | $14,800,551 | dollars as filed | |
| MBX BIOSCIENCES INC COM | 55287L101 | Stock | 1,294,416 | $14,769,287 | dollars as filed | |
| COMPASS THERAPEUTICS INC | 20454B104 | COM | 5,622,505 | $14,618,513 | dollars as filed | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 395,700 | $14,387,652 | dollars as filed | |
| JANUX THERAPEUTICS INC | 47103J105 | COM | 614,282 | $14,189,914 | dollars as filed | |
| TARSUS PHARMACEUTICALS INC | 87650L103 | COMMON STOCK | 341,496 | $13,834,003 | dollars as filed | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 1,446,361 | $13,769,357 | dollars as filed | |
| VERA THERAPEUTICS INC | 92337R101 | COMMON STOCK | 563,075 | $13,266,047 | dollars as filed | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 428,975 | $12,337,321 | dollars as filed | |
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 315,722 | $11,615,412 | dollars as filed | |
| AKEBIA THERAPEUTICS INC | 00972D105 | COMMON STOCK | 2,889,125 | $10,516,415 | dollars as filed | |
| OLEMA PHARMACEUTICALS INC | 68062P106 | COM | 2,378,762 | $10,133,526 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 323,398 | $10,122,357 | dollars as filed | |
| WAVE LIFE SCIENCES LTD SHS | Y95308105 | Stock | 1,505,262 | $9,784,203 | dollars as filed | |
| DBV TECHNOLOGIES S A | 23306J309 | SPONSORED ADS | 1,054,504 | $9,648,712 | dollars as filed | |
| CONTEXT THERAPEUTICS INC | 21077P108 | COM | 14,705,882 | $9,635,294 | dollars as filed | |
| ROCKET PHARMACEUTICALS INC | 77313F106 | COM | 3,903,081 | $9,562,548 | dollars as filed | |
| REPLIMUNE GROUP INC | 76029N106 | COMMON STOCK | 983,780 | $9,139,316 | dollars as filed | |
| NUVATION BIO INC COM CL A | 67080N101 | Stock | 4,622,590 | $9,014,051 | dollars as filed | |
| STOKE THERAPEUTICS INC | 86150R107 | COM | 789,698 | $8,963,072 | dollars as filed | |
| SOLID BIOSCIENCES INC | 83422E204 | COMMON STOCK | 1,634,569 | $7,960,351 | dollars as filed | |
| RELAY THERAPEUTICS INC COM | 75943R102 | Stock | 2,282,680 | $7,898,073 | dollars as filed | |
| CARTESIAN THERAPEUTICS INC | 816212302 | COMMON STOCK | 686,007 | $7,127,613 | dollars as filed | |
| TAYSHA GENE THERAPIES INC | 877619106 | COMMON STOCK | 2,953,562 | $6,822,728 | dollars as filed | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 321,696 | $5,501,002 | dollars as filed | |
| SOLENO THERAPEUTICS INC | 834203309 | COM | 50,000 | $4,189,000 | dollars as filed | |
| Veru Inc | 92536C103 | Common Stock | 4,911,948 | $2,857,771 | dollars as filed | |
| WEREWOLF THERAPEUTICS INC | 95075A107 | CMN | 2,408,810 | $2,625,603 | dollars as filed | |
| DESIGN THERAPEUTICS INC | 25056L103 | COM | 555,187 | $1,870,980 | dollars as filed | |
| REPARE THERAPEUTICS INC | 760273102 | COM | 819,924 | $1,139,694 | dollars as filed | |
| ADAPTIMMUNE THERAPEUTICS PLC | 00653A107 | SPONDS ADR | 4,411,821 | $1,057,513 | dollars as filed | |
| ARCELLX INC COMMON STOCK | 03940C100 | Stock | 37 | $2,436 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000950123-25-008431 | this filing | 2025-08-14 | acceptance time not in the bulk data set |